Medical Technology

@xconomy.com 3 years ago

Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More

@xconomy.com 4 years ago

Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More

@xconomy.com 5 years ago

Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More

@xconomy.com 5 years ago

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More

@xconomy.com 5 years ago

Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More

@xconomy.com 5 years ago

Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline

@xconomy.com 5 years ago

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

@xconomy.com 5 years ago

Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More

@xconomy.com 6 years ago

United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed

@xconomy.com 6 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs